PR Newswire
OAKLAND, Calif.
,
June 10, 2021
/PRNewswire/ –
Harborside Inc.
(“Harborside” or the “Company”) (CSE: HBOR),(OTCQX: HBORF) a
California
-focused, vertically integrated cannabis enterprise, today announced that it has executed a settlement and release agreement (the ”
Settlement Agreement
“) in respect of the previously disclosed litigation between the Company and a former employee. Pursuant to the settlement agreement, the Company has agreed to a one-time payment, net of insurance coverage, of approximately
US$1.5
million to settle all aspects of the litigation, which was initiated by the plaintiff in
June 2018
. More than half of the settlement amount was previously reserved by the Company in Q4 2019 and the settlement payment was incurred to eliminate substantial future legal costs and will resolve all issues relating to the matter.
For the latest news, activities, and media coverage, please visit the Harborside corporate website at
www.investharborside.com
or connect with us on
LinkedIn
,
About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in
California
, operating three of the major dispensaries in the
San Francisco Bay Area
, a dispensary in the
Palm Springs
area outfitted with
Southern California’s
only cannabis drive-thru window, a dispensary in
Oregon
and a cultivation/production facility in
Salinas, California
. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of
California
consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in
the United States
and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the Canadian Securities Exchange (“CSE”) trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at
www.sedar.com
.
Cautionary Note Regarding Forward-Looking Information
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company’s operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political, social and environmental uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations; the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates; and the risk factors set out in the Company’s management’s discussion and analysis for the quarter ended
March 31, 2021
and the Company’s listing statement dated
May 30, 2019
, which are available under the Company’s profile on
www.sedar.com
. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
The Company, through several of its subsidiaries, is indirectly involved in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis marketplace in
the United States
. Local state laws where the Company operates permit such activities however, investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in
the United States
. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in
the United States
to, among other things, cultivate, distribute or possess cannabis in
the United States
. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in
the United States
may form the basis for prosecution under applicable US federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in
the United States
has trended toward non-enforcement against individuals and businesses that comply with recreational and medicinal cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in
the United States
is a significant risk to the business of the Company and any proceedings brought against the Company thereunder may adversely affect the Company’s operations and financial performance.
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
http://www.prnewswire.com/news-releases/harborside-inc-announces-resolution-of-claim-301310043.html
SOURCE Harborside Inc.
